首页> 外文期刊>World Journal of Gastroenterology >Detection of gelatinase B activity in serum of gastric cancer patients.
【24h】

Detection of gelatinase B activity in serum of gastric cancer patients.

机译:胃癌患者血清中明胶酶B活性的检测。

获取原文
获取原文并翻译 | 示例
           

摘要

AIM: To determine the proteolytic activity and expression of gelatinase B in serum of gastric cancer patients and their correlation with the stage of the tumor. METHODS: Sera from 23 patients who underwent surgery for primary gastric cancer as the experimental group and from 11 as the control group were used to determine the proteolytic activity and its inhibition by EDTA and 1,10-phenanthroline. Gelatinase B activity was detected by SDS polyacrylamide gel electrophoresis (SDS-PAGE) and SDS-PAGE zymography. RESULTS: Proteolytic enzyme activity was increased in gastric cancer patients when compared to the control group (P < 0.05). The proteinases were determined to be metalloproteinases upon inhibition test with specific metalloproteinase inhibitors 1,10-phenanthroline (P < 0.05) and EDTA (P < 0.01). SDS-PAGE and SDS-PAGE zymography revealed gelatinase B (proMMP-9) activity and its molecular mass of 92 ku. CONCLUSION: Proteinase activity is overexpressed in serum of gastric cancer patients. Gelatinase Bin serum plays an important role in the progression of gastric cancer. ProMMP-9 can be used as a marker for invasiveness of gastric cancer.
机译:目的:确定胃癌患者血清中的蛋白水解活性和明胶酶B的表达及其与肿瘤分期的关系。方法:以23例行原发性胃癌手术的患者为实验组,以11例为对照组的血清,测定EDTA和1,10-菲咯啉的蛋白水解活性及其抑制作用。通过SDS聚丙烯酰胺凝胶电泳(SDS-PAGE)和SDS-PAGE酶谱法检测明胶酶B活性。结果:与对照组相比,胃癌患者的蛋白水解酶活性增加(P <0.05)。经特定金属蛋白酶抑制剂1,10-菲咯啉(P <0.05)和EDTA(P <0.01)的抑制试验,确定该蛋白酶为金属蛋白酶。 SDS-PAGE和SDS-PAGE酶谱显示明胶酶B(proMMP-9)活性及其分子量为92 ku。结论:蛋白酶活性在胃癌患者血清中过表达。明胶酶Bin血清在胃癌的进展中起重要作用。 ProMMP-9可用作胃癌浸润的标志物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号